Intuitive Surgical Shares Purchased by RWA Wealth Partners

Investment firm increases stake in medical robotics company by over 50%

Published on Feb. 26, 2026

RWA Wealth Partners LLC raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 50.2% during the third quarter, according to the company's recent 13F filing with the Securities & Exchange Commission. The investment firm now owns 11,609 shares of the medical equipment provider's stock, valued at $5,192,000.

Why it matters

Intuitive Surgical is a leading provider of robotic-assisted surgical systems, with its flagship da Vinci platform used in a wide range of minimally invasive procedures. The increased investment by RWA Wealth Partners signals confidence in the company's long-term growth potential as demand for advanced surgical technologies continues to rise.

The details

RWA Wealth Partners' purchase of an additional 3,881 Intuitive Surgical shares during the third quarter brings the firm's total holdings to 11,609 shares. This represents a 50.2% increase in the firm's stake in the medical equipment provider. Intuitive Surgical's stock has seen fluctuations in recent quarters, trading between $425 and $603 over the past 12 months, but the company remains a leader in the robotic surgery market.

  • RWA Wealth Partners increased its Intuitive Surgical stake during the third quarter of 2025.

The players

RWA Wealth Partners LLC

An investment management firm that has increased its stake in Intuitive Surgical, a leading provider of robotic surgical systems.

Intuitive Surgical, Inc.

A medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems, best known for its da Vinci surgical platforms.

Got photos? Submit your photos here. ›

The takeaway

Intuitive Surgical's continued leadership in the robotic surgery market is attracting increased investment interest, as demonstrated by RWA Wealth Partners' substantial increase in its stake in the company. This signals confidence in Intuitive Surgical's ability to capitalize on the growing demand for advanced surgical technologies that can improve patient outcomes and reduce recovery times.